ResearcherAjou UniversityActive in the last 2 years
Sang Gyu Park
Matched on ORCID iD 0000-0002-4870-2242; OpenAlex author ID A5101847178. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 1
2025: 3 papers
Papers 3
- Enhancing anti-tumor immunity through TIGIT blockade and tumor-directed targeting in pancreatic cancer. Last author DOI 10.1016/j.intimp.2025.115653↗
- Corrigendum to "Enhancing anti-tumor immunity through TIGIT blockade and tumor-directed targeting in pancreatic cancer" [Int. Immunopharmacol. 167 (2025) 11565… Last author DOI 10.1016/j.intimp.2025.115722↗
- CDCP1-targeting ADC outperforms standard therapies in Ras-mutant pancreatic cancer. Last author DOI 10.1016/j.omton.2025.201024↗
Closest collaborators
The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yun Jung Um · 3 shared papers, 2025 · strength 0.70
- Paper CDCP1-targeting ADC outperforms standard therapies in Ras-mutant pancreatic cancer. DOI 10.1016/j.omton.2025.201024↗
- Paper Enhancing anti-tumor immunity through TIGIT blockade and tumor-directed targeting in pancreatic cancer. DOI 10.1016/j.intimp.2025.115653↗
- Paper Corrigendum to "Enhancing anti-tumor immunity through TIGIT blockade and tumor-directed targeting in pancreatic cancer"… DOI 10.1016/j.intimp.2025.115722↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.